Prospective identification and characterization of breast cancer stem cells
OwnerMichael Clarke, Max Wicha +1inventors
InventorsMichael Clarke, Max Wicha, Muhammad Al-Hajj
Life of this patent
Estimating the term…
Loading patent…
OwnerMichael Clarke, Max Wicha +1inventors
InventorsMichael Clarke, Max Wicha, Muhammad Al-Hajj
Estimating the term…
Human breast tumors contain hetrogeneous cancer cells. using an animal xenograft model in which human breast cancer cells were grown in immunocompromised mice we found that only a small minority of breast cancer cells had capacity to form new tumors. The ability to form new tumors was not a slochastic property, rather certain populations of cancer cells were depleted for the ability to form new tumors, while other populations were enriched for the ability to form new tumors. Tumorigenic cells could be distinguished from non-tumorigenic cancer cells based on surface marker expression. We prospectively identified and isolated the tumorigenic cells as CD4430CD24−/lowLINEAGE A few as 100 cells from this population were able to form tumors the animal xenograft model, while tens of thousands of cells from non-tumorigenic populations failed to form tumors. The tumorigenic cells could be serially passaged, each time generating new tumors containing and expanded numbers of CD44+CD24 Lineage tumorigenic cells as well as phenotypically mixed populations of non-tumorigenic cancer cells. This is reminiscent of the ability of normal stem cells to self-renew and differentiate. The expression of potential therapeutic targets also differed between the tumorigenic and non-tumorigenic populations. Notch activation promoted the survival of the tumorigenic cells, and a blocking antibody against Notch 4 induced tumorigenic breast cancer cells to undergo apoptosis.
A method for reducing the size of a solid tumor, comprising the step of:
A method for reducing the size of a solid tumor, comprising:
A method for reducing the size of a solid tumor, comprising:
A method for killing or inhibiting the proliferation of solid tumor stem cells, comprising the step of:
A method for reducing the size of a solid tumor, comprising the step of:
A method for selectively targeting a solid tumor stem cell, comprising the steps of:
A biomolecule or set of biomolecules that is selectively targeted to solid tumor stem cell.
A method for forming a tumor in an animal, comprising:
Dependencies are inferred from the claim text.